California Public Employees Retirement System’s Gyre Therapeutics GYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-119
Closed -$9K 3415
2016
Q4
$9K Hold
119
﹤0.01% 3416
2016
Q3
$16K Hold
119
﹤0.01% 3449
2016
Q2
$20K Hold
119
﹤0.01% 3513
2016
Q1
$23K Hold
119
﹤0.01% 3529
2015
Q4
$42K Hold
119
﹤0.01% 3502
2015
Q3
$63K Hold
119
﹤0.01% 3485
2015
Q2
$262K Hold
119
﹤0.01% 3178
2015
Q1
$239K Hold
119
﹤0.01% 3335
2014
Q4
$239K Hold
119
﹤0.01% 3335
2014
Q3
$238K Hold
119
﹤0.01% 3320
2014
Q2
$424K Buy
119
+15
+14% +$49K ﹤0.01% 3072
2014
Q1
$369K Hold
104
﹤0.01% 3131
2013
Q4
$339K Sell
104
-2
-2% -$7.88K ﹤0.01% 3127
2013
Q3
$442K Buy
106
+13
+14% +$52.3K ﹤0.01% 2832
2013
Q2
$313K Buy
+93
New +$354K ﹤0.01% 2910

Other funds holding GYRE

California Public Employees Retirement System's GYRE Position: Q1 2017 in Review

California Public Employees Retirement System sold out of Gyre Therapeutics (GYRE) in Q1 2017, closing a stake of 119 shares — an estimated $9K sold.

California Public Employees Retirement System first reported a position in GYRE in Q2 2013 and held it in 15 quarters. The position peaked at $442K in Q3 2013. 17 funds tracked by Wall St. Rank hold GYRE as of Q1 2017.

  • California Public Employees Retirement System reported no remaining Gyre Therapeutics position as of Q1 2017 after selling out during the quarter.
  • California Public Employees Retirement System sold 119 Gyre Therapeutics shares in Q1 2017, an estimated $9K.
  • California Public Employees Retirement System first reported a position in Gyre Therapeutics in Q2 2013 and held it in 15 quarters.
  • California Public Employees Retirement System's Gyre Therapeutics position peaked at $442K in Q3 2013.
  • 17 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q1 2017.

Based on California Public Employees Retirement System's 13F filing for Q1 2017, filed 11 May 2017.